收费全文 | 19282篇 |
免费 | 1090篇 |
国内免费 | 62篇 |
耳鼻咽喉 | 327篇 |
儿科学 | 819篇 |
妇产科学 | 345篇 |
基础医学 | 2215篇 |
口腔科学 | 520篇 |
临床医学 | 1281篇 |
内科学 | 4725篇 |
皮肤病学 | 510篇 |
神经病学 | 1212篇 |
特种医学 | 572篇 |
外国民族医学 | 2篇 |
外科学 | 2992篇 |
综合类 | 383篇 |
一般理论 | 11篇 |
预防医学 | 1274篇 |
眼科学 | 478篇 |
药学 | 1532篇 |
中国医学 | 86篇 |
肿瘤学 | 1150篇 |
2023年 | 112篇 |
2022年 | 186篇 |
2021年 | 568篇 |
2020年 | 311篇 |
2019年 | 478篇 |
2018年 | 693篇 |
2017年 | 437篇 |
2016年 | 459篇 |
2015年 | 476篇 |
2014年 | 644篇 |
2013年 | 883篇 |
2012年 | 1337篇 |
2011年 | 1470篇 |
2010年 | 784篇 |
2009年 | 630篇 |
2008年 | 1173篇 |
2007年 | 1188篇 |
2006年 | 1136篇 |
2005年 | 1044篇 |
2004年 | 948篇 |
2003年 | 830篇 |
2002年 | 769篇 |
2001年 | 374篇 |
2000年 | 403篇 |
1999年 | 363篇 |
1998年 | 142篇 |
1997年 | 95篇 |
1996年 | 100篇 |
1995年 | 95篇 |
1994年 | 83篇 |
1993年 | 50篇 |
1992年 | 156篇 |
1991年 | 145篇 |
1990年 | 136篇 |
1989年 | 149篇 |
1988年 | 124篇 |
1987年 | 124篇 |
1986年 | 110篇 |
1985年 | 112篇 |
1984年 | 100篇 |
1983年 | 102篇 |
1982年 | 65篇 |
1981年 | 52篇 |
1980年 | 46篇 |
1979年 | 78篇 |
1978年 | 52篇 |
1977年 | 46篇 |
1974年 | 71篇 |
1973年 | 54篇 |
1969年 | 46篇 |
Objective
Comparative survival between neoadjuvant chemotherapy and adjuvant chemotherapy for patients with cT2-4N0-1M0 non–small cell lung cancer has not been extensively studied.Methods
Patients with cT2-4N0-1M0 non–small cell lung cancer who received platinum-based chemotherapy were retrospectively identified. Exclusion criteria included stage IV disease, induction radiotherapy, and targeted therapy. The primary end point was disease-free survival. Secondary end points were overall survival, chemotherapy tolerance, and ability of Response Evaluation Criteria In Solid Tumors response to predict survival. Survival was estimated using the Kaplan–Meier method, compared using the log-rank test and Cox proportional hazards models, and stratified using matched pairs after propensity score matching.Results
In total, 330 patients met the inclusion criteria (n = 92/group after propensity-score matching; median follow-up, 42 months). Five-year disease-free survival was 49% (95% confidence interval, 39-61) for neoadjuvant chemotherapy versus 48% (95% confidence interval, 38-61) for adjuvant chemotherapy (P = .70). On multivariable analysis, disease-free survival was not associated with neoadjuvant chemotherapy or adjuvant chemotherapy (hazard ratio, 1.1; 95% confidence interval, 0.64-1.90; P = .737), nor was overall survival (hazard ratio, 1.21; 95% confidence interval, 0.63-2.30; P = .572). The neoadjuvant chemotherapy group was more likely to receive full doses and cycles of chemotherapy (P = .014/0.005) and had fewer grade 3 or greater toxicities (P = .001). Response Evaluation Criteria In Solid Tumors response to neoadjuvant chemotherapy was associated with disease-free survival (P = .035); 15% of patients receiving neoadjuvant chemotherapy (14/92) had a major pathologic response.Conclusions
Timing of chemotherapy, before or after surgery, is not associated with an improvement in overall or disease-free survival among patients with cT2-4N0-1M0 non–small cell lung cancer who undergo complete surgical resection. 相似文献Background
Multiple myeloma (MM) is a hematologic malignancy of plasma cell origin. MM primarily affects bone marrow, but extramedullary sites can also be involved. Myelomatous pleural effusion (MPE) is an atypical and rare complication of MM. We aimed to systematically study the incidence and clinicopathologic profile of patients with MPE in a real-world setting.Patients and Methods
In this retrospective study, 415 consecutive patients with MM managed at a tertiary care center in North India during a study period of January 1, 2010 to December 31, 2015 were evaluated for MPE. The patients with MPE were analyzed for their clinical profile, diagnosis, treatment, and outcomes.Results
Of these 415 patients, 11 (2.65%) patients had MPE. The median age of the study population was 50 years with male preponderance. The majority of these patients had immunoglobin (Ig)G Kappa disease. All patients had higher than International Staging System stage I disease. MPE was a presenting feature at MM diagnosis in 45.45% (n = 5) of the patients, whereas the rest developed MPE during follow-up. MPE presented predominantly (81.8%) as a unilateral effusion. Concurrent extramedullary involvement at other site was seen in 45.45% (n = 5), with 3 (27%) patients having concurrent myelomatous ascites. Six of these were managed aggressively, whereas 5 patients opted for palliation. The outcomes were dismal (90.9% mortality), with a median survival of 2.47 months.Conclusion
MPE is a rare entity, and positive outcomes of therapy remain low with dismal prognosis. 相似文献Methods: The purpose of this study was to examine the degree to which several personal factors and school characteristics affect and explain students’ self-determination. A total of 232 students with intellectual disability from Spain participated. Their self-determination level was assessed by the ARC-INICO Scale.
Results: Students with moderate levels of intellectual disability obtained significantly lower scores on self-determination than their peers with mild intellectual disability. There were significant differences in relation to the level of support needs and their experience with transition programs. The level of support needs was a significant predictor.
Conclusion: These findings contribute to current research in this field and practical implications were discussed. 相似文献
![点击此处可从《Journal of clinical nursing》网站下载免费的PDF全文](/ch/ext_images/free.gif)